Ledger.Open graph →

SEC Form D · filed July 21, 2023

NFlection Therapeutics, Inc

Offering

$4.0M

Sold

$4.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

BOSTON, MA

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

William Hodder · Boston, MAExec · Director Ketan Patel · Boston, MADirector Josh Grass · Boston, MADirector Corey Goodman · Boston, MADirector Justin Polce · Mountainside, NJDirector Suresh Rajan · Westport, CTDirector Blas Jacob Cabrera · Claymont, DEDirector Christine A. Janofsky · SAN FRANCISCO, CAExec · Director Christopher Powala · Wayne, PADirector Paul More · Calgary, Alberta, CanadaDirector Jason Latkowcer · Calgary, Alberta, CanadaExec · Director William Gibbs · Calgary, Alberta, CanadaDirector Stuart Lander · Santa Monica, CADirector Christopher Powala · MALVERN, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗